TCEE treatment induced expression of cell cycle inhibitors, P21 and P27, as well as activation of apoptosis executer enzyme, caspase-3, on tested hepatocellular carcinoma cells. The gene discussed is CASP3; the disease is hepatocellular carcinoma.